Marcin Miszczyk

Featured in: Favicon

nature.com Favicon

europeanurology.com (+1) Favicon

onlinelibrary.wiley.com

Articles

Salvage therapies for biochemical recurrence after definitive local treatment: a systematic review, meta-analysis, and network meta-analysis - Prostate Cancer and Prostatic Diseases

Sep 12, 2024 | nature.com | Akihiro Matsukawa |Takafumi Yanagisawa |Marcin Miszczyk |Ichiro Tsuboi |Ekaterina Laukhtina |Juan Rivas | +4 more

AbstractRecent advancements in the management of biochemical recurrence (BCR) following local treatment for prostate cancer (PCa), including the use of androgen receptor signaling inhibitors (ARSIs), have broadened the spectrum of therapeutic options. We aimed to compare salvage therapies in patients with BCR after definitive local treatment for clinically non-metastatic PCa with curative intent.
The Efficacy and Safety of Metastasis-directed Therapy in Patients with Prostate Cancer: A Systematic Review and Meta-analysis of Prospective Studies

Nov 7, 2023 | europeanurology.com | Marcin Miszczyk |IIIrd Radiotherapy |Markus von Deimling |Benjamin Pradere

AbstractDespite the lack of level 1 evidence, metastasis-directed therapy (MDT) is used widely in the management of metastatic prostate cancer (mPCa) patients. Data are continuously emerging from well-designed prospective studies. To summarise and report the evidence on oncological and safety outcomes of MDT in the management of mPCa patients.

Contact details

Emails

[email protected]

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →